Karen E. Parrish

1.1k total citations
21 papers, 734 citations indexed

About

Karen E. Parrish is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Karen E. Parrish has authored 21 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 10 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Karen E. Parrish's work include Glioma Diagnosis and Treatment (10 papers), Drug Transport and Resistance Mechanisms (5 papers) and PARP inhibition in cancer therapy (4 papers). Karen E. Parrish is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Drug Transport and Resistance Mechanisms (5 papers) and PARP inhibition in cancer therapy (4 papers). Karen E. Parrish collaborates with scholars based in United States, Germany and Sweden. Karen E. Parrish's co-authors include William F. Elmquist, Jann N. Sarkaria, Rajendar K. Mittapalli, Terence T. Sio, Rajneet K. Oberoi, Katrina K. Bakken, Janice K. Laramy, Sani H. Kizilbash, Gautham Gampa and Minjee Kim and has published in prestigious journals such as Cancer Research, Scientific Reports and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Karen E. Parrish

21 papers receiving 721 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karen E. Parrish United States	14	315	309	276	150	116	21	734
Janice K. Laramy United States	9	227 0.7×	228 0.7×	312 1.1×	132 0.9×	164 1.4×	11	702
Nienke A. de Vries Netherlands	12	593 1.9×	436 1.4×	272 1.0×	158 1.1×	76 0.7×	13	1.0k
Levi C.M. Buil Netherlands	15	348 1.1×	506 1.6×	249 0.9×	125 0.8×	53 0.5×	22	912
Constantinos Alifieris Greece	7	334 1.1×	400 1.3×	214 0.8×	125 0.8×	153 1.3×	15	998
Luiz Gustavo Dubois Brazil	16	158 0.5×	423 1.4×	308 1.1×	73 0.5×	122 1.1×	20	889
Jenny L. Pokorny United States	13	405 1.3×	719 2.3×	496 1.8×	151 1.0×	96 0.8×	21	1.2k
Vinay Rudraraju United States	3	438 1.4×	224 0.7×	262 0.9×	440 2.9×	144 1.2×	3	857
Bakhtiar Yamini United States	20	158 0.5×	487 1.6×	269 1.0×	88 0.6×	88 0.8×	44	1.0k
Nazanin Majd United States	13	192 0.6×	337 1.1×	347 1.3×	111 0.7×	61 0.5×	63	799
Niyati Jhaveri United States	12	115 0.4×	302 1.0×	182 0.7×	66 0.4×	109 0.9×	15	636

Countries citing papers authored by Karen E. Parrish

Since Specialization

Citations

This map shows the geographic impact of Karen E. Parrish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen E. Parrish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen E. Parrish more than expected).

Fields of papers citing papers by Karen E. Parrish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen E. Parrish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen E. Parrish. The network helps show where Karen E. Parrish may publish in the future.

Co-authorship network of co-authors of Karen E. Parrish

This figure shows the co-authorship network connecting the top 25 collaborators of Karen E. Parrish. A scholar is included among the top collaborators of Karen E. Parrish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen E. Parrish. Karen E. Parrish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yihan, Heather Jackson, Yuting Wang, et al.. (2025). A novel in vitro serum stability assay for antibody therapeutics incorporating internal standards. mAbs. 17(1). 2479529–2479529. 1 indexed citations

Kizilbash, Sani H., Shiv K. Gupta, Karen E. Parrish, et al.. (2021). In Vivo Efficacy of Tesevatinib in EGFR -Amplified Patient-Derived Xenograft Glioblastoma Models May Be Limited by Tissue Binding and Compensatory Signaling. Molecular Cancer Therapeutics. 20(6). 1009–1018. 10 indexed citations

Degnan, Andrew P., Walter L. Johnson, Kurt Zimmermann, et al.. (2021). Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1. ACS Medicinal Chemistry Letters. 12(3). 443–450. 36 indexed citations

Gampa, Gautham, Rajappa S. Kenchappa, Afroz S. Mohammad, et al.. (2020). Enhancing Brain Retention of a KIF11 Inhibitor Significantly Improves its Efficacy in a Mouse Model of Glioblastoma. Scientific Reports. 10(1). 6524–6524. 21 indexed citations

Zhu, Yongxin, Bogdan Sleczka, Karen E. Parrish, et al.. (2020). Immunoaffinity microflow liquid chromatography/tandem mass spectrometry for the quantitation of PD1 and PD‐L1 in human tumor tissues. Rapid Communications in Mass Spectrometry. 34(20). e8896–e8896. 5 indexed citations

Parrish, Karen E., Lihong Cheng, Paul Stetsko, et al.. (2020). Pharmacodynamics‐based approach for efficacious human dose projection of BMS‐986260, a small molecule transforming growth factor beta receptor 1 inhibitor. Biopharmaceutics & Drug Disposition. 42(4). 137–149. 2 indexed citations

Laramy, Janice K., Gautham Gampa, Karen E. Parrish, et al.. (2019). Brain Distributional Kinetics of a Novel MDM2 Inhibitor SAR405838: Implications for Use in Brain Tumor Therapy. Drug Metabolism and Disposition. 47(12). 1403–1414. 15 indexed citations

Gampa, Gautham, Minjee Kim, Afroz S. Mohammad, et al.. (2019). Brain Distribution and Active Efflux of Three panRAF Inhibitors: Considerations in the Treatment of Melanoma Brain Metastases. Journal of Pharmacology and Experimental Therapeutics. 368(3). 446–461. 16 indexed citations

Laramy, Janice K., Minjee Kim, Karen E. Parrish, Jann N. Sarkaria, & William F. Elmquist. (2018). Pharmacokinetic Assessment of Cooperative Efflux of the Multitargeted Kinase Inhibitor Ponatinib Across the Blood-Brain Barrier. Journal of Pharmacology and Experimental Therapeutics. 365(2). 249–261. 29 indexed citations

10.

Kim, Minjee, Sani H. Kizilbash, Janice K. Laramy, et al.. (2018). Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine. Pharmaceutical Research. 35(9). 52 indexed citations

11.

Kizilbash, Sani H., Shiv K. Gupta, Kenneth Tou En Chang, et al.. (2017). Restricted Delivery of Talazoparib Across the Blood–Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma. Molecular Cancer Therapeutics. 16(12). 2735–2746. 60 indexed citations

12.

Laramy, Janice K., Minjee Kim, Shiv K. Gupta, et al.. (2017). Heterogeneous Binding and Central Nervous System Distribution of the Multitargeted Kinase Inhibitor Ponatinib Restrict Orthotopic Efficacy in a Patient-Derived Xenograft Model of Glioblastoma. Journal of Pharmacology and Experimental Therapeutics. 363(2). 136–147. 21 indexed citations

13.

Mittapalli, Rajendar K., Karen E. Parrish, Donna Crabtree, et al.. (2016). ABCG2 and ABCB1 Limit the Efficacy of Dasatinib in a PDGF-B–Driven Brainstem Glioma Model. Molecular Cancer Therapeutics. 15(5). 819–829. 51 indexed citations

14.

Gampa, Gautham, Shruthi Vaidhyanathan, Karen E. Parrish, et al.. (2016). Challenges in the Delivery of Therapies to Melanoma Brain Metastases. Current Pharmacology Reports. 2(6). 309–325. 13 indexed citations

15.

Kizilbash, Sani H., Kenneth Tou En Chang, Shiv K. Gupta, et al.. (2016). Abstract 340: Talazoparib enhances low-dose temozolomide efficacy in flank glioblastoma models, but intracranial efficacy is constrained by limited brain distribution. Cancer Research. 76(14_Supplement). 340–340. 1 indexed citations

16.

Parrish, Karen E., Ling Cen, J. C. Murray, et al.. (2015). Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System. Molecular Cancer Therapeutics. 14(12). 2735–2743. 66 indexed citations

17.

Oberoi, Rajneet K., Karen E. Parrish, Terence T. Sio, et al.. (2015). Strategies to improve delivery of anticancer drugs across the blood–brain barrier to treat glioblastoma. Neuro-Oncology. 18(1). 27–36. 217 indexed citations

18.

Parrish, Karen E., Jenny L. Pokorny, Rajendar K. Mittapalli, et al.. (2015). Efflux Transporters at the Blood-Brain Barrier Limit Delivery and Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor Palbociclib (PD-0332991) in an Orthotopic Brain Tumor Model. Journal of Pharmacology and Experimental Therapeutics. 355(2). 264–271. 75 indexed citations

19.

Vaidhyanathan, Shruthi, Dongjun Ma, Karen E. Parrish, et al.. (2015). Factors Influencing the Central Nervous System Distribution of a Novel Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor GSK2126458: Implications for Overcoming Resistance with Combination Therapy for Melanoma Brain Metastases. Journal of Pharmacology and Experimental Therapeutics. 356(2). 251–259. 15 indexed citations

20.

Parrish, Karen E., Jialin Mao, Jacob Chen, et al.. (2015). In vitroandin vivocharacterization of CYP inhibition by 1‐aminobenzotriazole in rats. Biopharmaceutics & Drug Disposition. 37(4). 200–211. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact